Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dose-finding for awake fiberoptic intubation in difficult airway otorhinolaryngologic surgery
ChiCTR2400091475Phase 4Recruiting
- Sponsor
- Eye and ENT Hospital of Fudan University
- Start
- Oct 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and fentanyl in difficult airway (3 arms), sponsored by Eye and ENT Hospital of Fudan University. Primary endpoints: Cough score, Tolerance after intubation and 1 more. Started Oct 2024; status: recruiting.
02
Drugs
dexmedetomidinefentanyl
03
Conditions
difficult airway
Beyond the preview
Go deeper on ChiCTR2400091475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091475.